| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |